{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:05:40Z","timestamp":1774699540351,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"DOI":"10.1007\/s11882-026-01266-5","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:43:37Z","timestamp":1774698217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychophysical Olfactory Outcomes After Biologic Therapy for Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4561-1556","authenticated-orcid":false,"given":"Christian K.","family":"Pedersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-7219","authenticated-orcid":false,"given":"Vibeke","family":"Backer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6924-1218","authenticated-orcid":false,"given":"Jens Even","family":"Tidemandsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1576-3679","authenticated-orcid":false,"given":"Simon","family":"H\u00f8j","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-0924","authenticated-orcid":false,"given":"Marie","family":"H\u00f8xbro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9716-6501","authenticated-orcid":false,"given":"Anne-Sophie","family":"Hom\u00f8e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7353-0817","authenticated-orcid":false,"given":"Kasper","family":"Aan\u00e6s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-8129","authenticated-orcid":false,"given":"Christian","family":"von Buchwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"1266_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","volume":"4","author":"WW Stevens","year":"2016","unstructured":"Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016;4:565\u201372. https:\/\/doi.org\/10.1016\/j.jaip.2016.04.012.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1266_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/all.13373","volume":"73","author":"K Samitas","year":"2018","unstructured":"Samitas K, Carter A, Kariyawasam HH, Xanthou G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2018;73:993\u20131002. https:\/\/doi.org\/10.1111\/all.13373.","journal-title":"Allergy"},{"key":"1266_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084313","author":"KM Hughes","year":"2022","unstructured":"Hughes KM, Price D, Torriero AAJ, Symonds MRE, Suphioglu C. Impact of fungal spores on asthma prevalence and hospitalization. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23084313.","journal-title":"Int J Mol Sci"},{"key":"1266_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2500\/ajra.2012.26.3762","volume":"26","author":"CH Feng","year":"2012","unstructured":"Feng CH, Miller MD, Simon RA. The united allergic airway: connections between allergic rhinitis, asthma, andchronic sinusitis. Am J Rhinol Allergy. 2012;26:187\u201390. https:\/\/doi.org\/10.2500\/ajra.2012.26.3762.","journal-title":"Am J Rhinol Allergy"},{"key":"1266_CR5","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1007\/s00405-025-09557-9","volume":"282","author":"D Li","year":"2025","unstructured":"Li D, Guo S, Cui S, Yu J, Liu Z, Wang K, et al. Development and validation of a clinical risk prediction model for chronic sinusitis with nasal polyps: a retrospective analysis. Eur Arch Otorhinolaryngol. 2025;282:4109\u201322. https:\/\/doi.org\/10.1007\/s00405-025-09557-9.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1266_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4193\/Rhin22.344","volume":"61","author":"PW Hellings","year":"2023","unstructured":"Hellings PW, Fokkens WJ, Orlandi R, Adriaensen GF, Alobid I, Baroody FM, et al. The EUFOREA pocket guide for chronic rhinosinusitis*. Rhinology. 2023;61:85\u20139. https:\/\/doi.org\/10.4193\/Rhin22.344.","journal-title":"Rhinology"},{"key":"1266_CR7","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.480","author":"PRG Eriksen","year":"2021","unstructured":"Eriksen PRG, Jakobsen KK, Aan\u00e6s K, Backer V, von Buchwald C. The potential role of biological treatment of chronic rhinosinusitis with nasal polyps: a nationwide cohort study*. Rhinology. 2021. https:\/\/doi.org\/10.4193\/Rhin20.480.","journal-title":"Rhinology"},{"key":"1266_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4193\/Rhin20.570","volume":"59","author":"PW Hellings","year":"2021","unstructured":"Hellings PW, Verhoeven E, Fokkens WJ. State-of-the-art overview on biological treatment for CRSwNP. Rhinology. 2021;59:151\u201363. https:\/\/doi.org\/10.4193\/Rhin20.570.","journal-title":"Rhinology"},{"key":"1266_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4193\/Rhin24.510","volume":"63","author":"WJ Fokkens","year":"2025","unstructured":"Fokkens WJ, Backer V, Lund VJ, Barnes PJ, Bernal-Sprekelsen M, Bjermer L, et al. Pocket guide: biologics in upper and lower airways in adults. Rhinology. 2025;63:242\u20134. https:\/\/doi.org\/10.4193\/Rhin24.510.","journal-title":"Rhinology"},{"key":"1266_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/falgy.2022.889221","volume":"3","author":"L De Prins","year":"2022","unstructured":"De Prins L, Raap U, Mueller T, Schmid-Grendelmeier P, Haase CH, Backer V, et al. White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA. Front Allergy. 2022;3:1\u201312. https:\/\/doi.org\/10.3389\/falgy.2022.889221.","journal-title":"Front Allergy"},{"key":"1266_CR11","doi-asserted-by":"publisher","DOI":"10.4193\/rhin22.489","author":"A Viskens","year":"2023","unstructured":"Viskens A, Backer V. EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinology. 2023. https:\/\/doi.org\/10.4193\/rhin22.489.","journal-title":"Rhinology"},{"key":"1266_CR12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ohn.627","volume":"170","author":"C Hopkins","year":"2024","unstructured":"Hopkins C, Mullol J, Khan AH, Lee SE, Wagenmann M, Hellings P, et al. Impact of Dupilumab on sinonasal symptoms and outcomes in severe chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg. 2024;170:1173\u201382. https:\/\/doi.org\/10.1002\/ohn.627.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1266_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin22.483","volume":"61","author":"KL Whitcroft","year":"2023","unstructured":"Whitcroft KL, Altundag A, Balungwe P, Douglas R, Enecilla MLB, Fjaeldstad AW, et al. Position paper on olfactory dysfunction. Rhinology. 2023;61:1\u2013108. https:\/\/doi.org\/10.4193\/Rhin22.483.","journal-title":"Rhinology"},{"key":"1266_CR14","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1007\/s12325-024-02984-w","volume":"41","author":"ZM Soler","year":"2024","unstructured":"Soler ZM, Nash S, Lane AP, Patel ZM, Lee SE, Fokkens WJ, et al. Reduced sense of smell in patients with severe chronic rhinosinusitis and its implications for diagnosis and management: a narrative review. Adv Ther. 2024;41:4384\u201395. https:\/\/doi.org\/10.1007\/s12325-024-02984-w.","journal-title":"Adv Ther"},{"key":"1266_CR15","doi-asserted-by":"publisher","unstructured":"Alobid I, Calvo-Henr\u00edquez C, Viveros-D\u00edez P, L\u00f3pez-Chac\u00f3n M, Rojas-Lechuga M, Langdon C, et al. Validation of Visual Analogue Scale for loss of smell as a quick test in chronic rhinosinusitis with nasal polyps. J Investig Allergy Clin Immunol. 2023;34:377\u201384. https:\/\/doi.org\/10.18176\/jiaci.0937.","DOI":"10.18176\/jiaci.0937"},{"key":"1266_CR16","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.jaip.2024.07.019","volume":"12","author":"AT Peters","year":"2024","unstructured":"Peters AT, Tan BK, Stevens WW. Consultation for chronic rhinosinusitis with nasal polyps and asthma: clinical presentation, diagnostic workup, and treatment options. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12:2898\u2013905. https:\/\/doi.org\/10.1016\/j.jaip.2024.07.019.","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"key":"1266_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4193\/Rhin23.415","volume":"62","author":"WJ Fokkens","year":"2024","unstructured":"Fokkens WJ, De Corso E, Backer V, Bernal-Sprekelsen M, Bjermer L, von Buchwald C, et al. EPOS2020\/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinology. 2024;62:287\u201398. https:\/\/doi.org\/10.4193\/Rhin23.415.","journal-title":"Rhinology"},{"key":"1266_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/00016489.2025.2458170","volume":"145","author":"M Bech","year":"2025","unstructured":"Bech M, Jakobsen KK, Andersen ISB, Pedersen CK, Gr\u00f8nlund MW, von Buchwald C. Which is superior, the University of Pennsylvania Smell Identification Test or the threshold, discrimination and identification test for testing human olfaction? A systematic review. Acta Otolaryngol. 2025;145:241\u20134. https:\/\/doi.org\/10.1080\/00016489.2025.2458170.","journal-title":"Acta Otolaryngol"},{"key":"1266_CR19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/all.15982","volume":"79","author":"PW Hellings","year":"2024","unstructured":"Hellings PW, Alobid I, Anselmo-Lima WT, Bernal-Sprekelsen M, Bjermer L, Caulley L, et al. EUFOREA\/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care. Allergy. 2024;79:1123\u201333. https:\/\/doi.org\/10.1111\/all.15982.","journal-title":"Allergy"},{"key":"1266_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:1\u20139. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1266_CR21","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD.","journal-title":"BMJ"},{"key":"1266_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:1\u20138. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"1266_CR23","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394:1638\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1.","journal-title":"Lancet"},{"key":"1266_CR24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","volume":"146","author":"P Gevaert","year":"2020","unstructured":"Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020;146:595\u2013605. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.032.","journal-title":"J Allergy Clin Immunol"},{"key":"1266_CR25","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","volume":"9","author":"JK Han","year":"2021","unstructured":"Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021;9:1141\u201353. https:\/\/doi.org\/10.1016\/S2213-2600(21)00097-7.","journal-title":"Lancet Respir Med"},{"key":"1266_CR26","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jaci.2025.01.034","volume":"155","author":"M Zheng","year":"2025","unstructured":"Zheng M, Wu D, Piao Y, Tang J, Quan F, Guan B, et al. Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: placebo-controlled phase 2 trial. J Allergy Clin Immunol. 2025;155:1575\u201383. https:\/\/doi.org\/10.1016\/j.jaci.2025.01.034.","journal-title":"J Allergy Clin Immunol"},{"key":"1266_CR27","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/cea.13852","volume":"51","author":"J Tversky","year":"2021","unstructured":"Tversky J, Lane AP, Azar A. Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): a randomized double-blind placebo-controlled trial. Clin Exp Allergy. 2021;51:836\u201344. https:\/\/doi.org\/10.1111\/cea.13852.","journal-title":"Clin Exp Allergy"},{"key":"1266_CR28","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1056\/NEJMoa2414482","volume":"392","author":"BJ Lipworth","year":"2025","unstructured":"Lipworth BJ, Han JK, Desrosiers M, Hopkins C, Lee SE, Mullol J, et al. Tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps. N Engl J Med. 2025;392:1178\u201388. https:\/\/doi.org\/10.1056\/NEJMoa2414482.","journal-title":"N Engl J Med"},{"key":"1266_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","volume":"315","author":"C Bachert","year":"2016","unstructured":"Bachert C, Mannen L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016;315:469\u201379. https:\/\/doi.org\/10.1001\/jama.2015.19330.","journal-title":"JAMA"},{"key":"1266_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00405-023-08184-6","volume":"281","author":"I La Mantia","year":"2024","unstructured":"La Mantia I, Grigaliute E, Ragusa M, Cocuzza S, Radulesco T, Saibene AM, et al. Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled study. Eur Arch Otorhinolaryngol. 2024;281:219\u201326. https:\/\/doi.org\/10.1007\/s00405-023-08184-6.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1266_CR31","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1007\/s00405-024-08574-4","volume":"281","author":"SO Sarnoch","year":"2024","unstructured":"Sarnoch SO, Pepi\u0107 A, Schmitz L, Becker B, Betz C, Hoffmann AS. The value of biomarkers in the therapy of CRSwNP with biologicals\u2014a long-term follow-up of dupilumab therapy. Eur Arch Otorhinolaryngol. 2024;281:4789\u2013805. https:\/\/doi.org\/10.1007\/s00405-024-08574-4.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1266_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40463-023-00663-4","volume":"52","author":"NJ Campion","year":"2023","unstructured":"Campion NJ, Brugger J, Tu A, Stanek V, Brkic FF, Bartosik TJ, et al. The \u201creal life\u201d efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP. J Otolaryngol-Head Neck Surg. 2023;52:1\u201312. https:\/\/doi.org\/10.1186\/s40463-023-00663-4.","journal-title":"J Otolaryngol-Head Neck Surg"},{"key":"1266_CR33","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/lary.31948","volume":"135","author":"S De Santis","year":"2025","unstructured":"De Santis S, Galassi S, Cambi J. Clinical effects and response time of biological drugs in chronic rhinosinusitis with nasal polyps patients: real-life experience. Laryngoscope. 2025;135:1628\u201335. https:\/\/doi.org\/10.1002\/lary.31948.","journal-title":"Laryngoscope"},{"key":"1266_CR34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/all.15134","volume":"77","author":"R Lans","year":"2022","unstructured":"Lans R, Fokkens WJ, Adriaensen GFJPM, Hoven DR, Drubbel JJ, Reitsma S. Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps. Allergy. 2022;77:670\u20134. https:\/\/doi.org\/10.1111\/all.15134.","journal-title":"Allergy"},{"key":"1266_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2023.1127576","volume":"14","author":"Z Danisman","year":"2023","unstructured":"Danisman Z, Linxweiler M, K\u00fchn JP, Linxweiler B, Solomayer EF, Wagner M, et al. Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with Dupilumab. Front Immunol. 2023;14:1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2023.1127576.","journal-title":"Front Immunol"},{"key":"1266_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2023.100780","author":"T Albrecht","year":"2023","unstructured":"Albrecht T, Sailer MM, Capitani F, van Schaik C, L\u00f6wenheim H, Becker S. Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy. World Allergy Organ J. 2023. https:\/\/doi.org\/10.1016\/j.waojou.2023.100780.","journal-title":"World Allergy Organ J"},{"key":"1266_CR37","doi-asserted-by":"publisher","first-page":"496","DOI":"10.4193\/Rhin23.476","volume":"62","author":"T Mauthe","year":"2024","unstructured":"Mauthe T, Meerwein CM, Ryser FS, Br\u00fchlmann C, Yalamanoglu A, Steiner UC, et al. Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps. Rhinology. 2024;62:496\u2013505. https:\/\/doi.org\/10.4193\/Rhin23.476.","journal-title":"Rhinology"},{"key":"1266_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4193\/Rhin22.469","volume":"61","author":"R B\u00f6scke","year":"2023","unstructured":"B\u00f6scke R, Heidemann M, Bruchhage KL. Dupilumab for chronic rhinosinusitis with nasal polyps: real-life retrospective 12-month effectiveness data*. Rhinology. 2023;61:203\u201313. https:\/\/doi.org\/10.4193\/Rhin22.469.","journal-title":"Rhinology"},{"key":"1266_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.anai.2024.07.001","volume":"133","author":"T Tajiri","year":"2024","unstructured":"Tajiri T, Suzuki M, Nishiyama H, Ozawa Y, Kurokawa R, Ito K, et al. Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma: a prospective study. Ann Allergy Asthma Immunol. 2024;133:550-558.e2. https:\/\/doi.org\/10.1016\/j.anai.2024.07.001.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1266_CR40","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1007\/s00405-024-08553-9","volume":"281","author":"A Gal","year":"2024","unstructured":"Gal A, Gravier-Dumonceau R, Penicaud M, Ebode D, Radulesco T, Michel J. Efficacy of dupilumab in real-life settings: a STROBE study. Eur Arch Otorhinolaryngol. 2024;281:4781\u20138. https:\/\/doi.org\/10.1007\/s00405-024-08553-9.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1266_CR41","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00405-022-07679-y","volume":"280","author":"F Jansen","year":"2023","unstructured":"Jansen F, Becker B, Eden JK, Breda PC, Hot A, Oqueka T, et al. Dupilumab (Dupixent\u00ae) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany. Eur Arch Otorhinolaryngol. 2023;280:1741\u201355. https:\/\/doi.org\/10.1007\/s00405-022-07679-y.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1266_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/1945892420961969","volume":"35","author":"SS Mustafa","year":"2021","unstructured":"Mustafa SS, Vadamalai K, Scott B, Ramsey A. Dupilumab as add-on therapy for chronic rhinosinusitis with nasal polyposis in aspirin exacerbated respiratory disease. Am J Rhinol Allergy. 2021;35:399\u2013407. https:\/\/doi.org\/10.1177\/1945892420961969.","journal-title":"Am J Rhinol Allergy"},{"key":"1266_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/all.15772","author":"E De Corso","year":"2023","unstructured":"De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, et al. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase IV real-life study (DUPIREAL). Allergy. 2023. https:\/\/doi.org\/10.1111\/all.15772.","journal-title":"Allergy"},{"key":"1266_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14091014","author":"E De Corso","year":"2024","unstructured":"De Corso E, Mele DA, Rizzi A, Spanu C, Corb\u00f2 M, Pisciottano S, et al. Sinonasal outcomes obtained after 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and CRSwNP: a \u201creal-life\u201d observational study. J Pers Med. 2024. https:\/\/doi.org\/10.3390\/jpm14091014.","journal-title":"J Pers Med"},{"key":"1266_CR45","doi-asserted-by":"publisher","first-page":"538","DOI":"10.14639\/0392-100X-N2156","volume":"42","author":"M Trimarchi","year":"2022","unstructured":"Trimarchi M, Vinciguerra A, Rampi A, Tanzini U, Nonis A, Yacoub MR, et al. A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation. Acta Otorhinolaryngol Ital. 2022;42:538\u201344. https:\/\/doi.org\/10.14639\/0392-100X-N2156.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"1266_CR46","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.26355\/eurrev_202308_33304","volume":"27","author":"D Mocellin","year":"2023","unstructured":"Mocellin D, Ioppi A, Gaglio G, Pennacchi A, Bertolini M, Tirrito A, et al. Severe chronic rhinosinusitis treated with dupilumab, a real-life analysis of early effectiveness. Eur Rev Med Pharmacol Sci. 2023;27:7324\u201336. https:\/\/doi.org\/10.26355\/eurrev_202308_33304.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1266_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2023.104106","author":"C Galletti","year":"2024","unstructured":"Galletti C, Ragusa M, Sireci F, Ciodaro F, Barbieri MA, Giunta G, et al. Dupilumab in chronic rhinosinusitis with nasal polyps: real life data in a multicentric Sicilian experience. Am J Otolaryngol. 2024. https:\/\/doi.org\/10.1016\/j.amjoto.2023.104106.","journal-title":"Am J Otolaryngol"},{"key":"1266_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines13020501","volume":"13","author":"GL Fadda","year":"2025","unstructured":"Fadda GL, Rustichelli C, Soccal S, Moglio S, Serrone A, Bertolini F, et al. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP) and comorbid asthma\u2014a multidisciplinary monocentric real-life study. Biomedicines. 2025;13:1\u201319. https:\/\/doi.org\/10.3390\/biomedicines13020501.","journal-title":"Biomedicines"},{"key":"1266_CR49","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/coa.14246","volume":"50","author":"A Maniaci","year":"2024","unstructured":"Maniaci A, Vertillo Aluisio G, Stefani S, Cocuzza S, Lechien JR, Radulesco T, et al. Differential nasal recolonization and microbial profiles in chronic rhinosinusitis with nasal polyps patients after endoscopic sinus surgery or dupilumab treatment: a prospective observational study. Clin Otolaryngol. 2024;50:262\u201370. https:\/\/doi.org\/10.1111\/coa.14246.","journal-title":"Clin Otolaryngol"},{"key":"1266_CR50","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/lary.31719","volume":"135","author":"A Maniaci","year":"2025","unstructured":"Maniaci A, Bonacci P, Stefani S, Cocuzza S, Merlino F, Saibene AM, et al. Influence of single nucleotide polymorphisms on CRS outcomes: a preliminary observational study. Laryngoscope. 2025;135:570\u20138. https:\/\/doi.org\/10.1002\/lary.31719.","journal-title":"Laryngoscope"},{"key":"1266_CR51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/lary.29888","volume":"132","author":"JK Han","year":"2022","unstructured":"Han JK, Bachert C, Lee SE, Hopkins C, Heffler E, Hellings PW, et al. Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2022;132:265\u201371. https:\/\/doi.org\/10.1002\/lary.29888.","journal-title":"Laryngoscope"},{"key":"1266_CR52","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/lary.20653","volume":"119","author":"C Hopkins","year":"2009","unstructured":"Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope. 2009;119:2459\u201365. https:\/\/doi.org\/10.1002\/lary.20653.","journal-title":"Laryngoscope"},{"key":"1266_CR53","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.jaci.2021.09.009","volume":"149","author":"P Oykhman","year":"2022","unstructured":"Oykhman P, Paramo FA, Bousquet J, Kennedy DW, Brignardello-Petersen R, Chu DK. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis. J Allergy Clin Immunol. 2022;149:1286\u201395. https:\/\/doi.org\/10.1016\/j.jaci.2021.09.009.","journal-title":"J Allergy Clin Immunol"},{"key":"1266_CR54","doi-asserted-by":"publisher","unstructured":"Barroso B, Valverde-Monge M, Betancor D, G\u00f3mez-L\u00f3pez A, Villalobos-Vildas C, Gonz\u00e1lez-Cano B, et al. Smell improvement in chronic rhinosinusitis with nasal polyps with monoclonal antibodies: a systematic review. J Investig Allergol Clin Immunol 2023;33:1\u201329. https:\/\/doi.org\/10.18176\/jiaci.0939.","DOI":"10.18176\/jiaci.0939"},{"key":"1266_CR55","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.jaip.2025.04.043","volume":"13","author":"BJ Lipworth","year":"2025","unstructured":"Lipworth BJ, Greig R, Chan R, Kuo CRW. Reappraisal of biologic efficacy from phase 3 trials in refractory chronic rhinosinusitis and nasal polyps. J Allergy Clin Immunol Pract. 2025;13:1943\u201351. https:\/\/doi.org\/10.1016\/j.jaip.2025.04.043.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1266_CR56","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","volume":"149","author":"C Bachert","year":"2022","unstructured":"Bachert C, Han JK, Desrosiers MY, Gevaert P, Heffler E, Hopkins C, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149:1309-1317.e12. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.030.","journal-title":"J Allergy Clin Immunol"},{"key":"1266_CR57","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/alr.23562","volume":"15","author":"AS Hom\u00f8e","year":"2025","unstructured":"Hom\u00f8e AS, Aan\u00e6s K, Tidemandsen JE, Holbaek HC, Niclas R, Badsberg SG, et al. Superior benefits of combining mepolizumab with sinus surgery compared to mepolizumab alone: results from a randomised 6-month trial. Int Forum Allergy Rhinol. 2025;15:724\u201333. https:\/\/doi.org\/10.1002\/alr.23562.","journal-title":"Int Forum Allergy Rhinol"},{"key":"1266_CR58","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1080\/13803391003683070","volume":"32","author":"M Hedner","year":"2010","unstructured":"Hedner M, Larsson M, Arnold N, Zucco GM, Hummel T. Cognitive factors in odor detection, odor discrimination, and odor identification tasks. J Clin Exp Neuropsychol. 2010;32:1062\u20137. https:\/\/doi.org\/10.1080\/13803391003683070.","journal-title":"J Clin Exp Neuropsychol"},{"key":"1266_CR59","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/chemse\/bjg061","volume":"28","author":"BN Landis","year":"2003","unstructured":"Landis BN, Hummel T, Hugentobler M, Giger R, Lacroix JS. Ratings of overall olfactory function. Chem Senses. 2003;28:691\u20134. https:\/\/doi.org\/10.1093\/chemse\/bjg061.","journal-title":"Chem Senses"},{"key":"1266_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(25)00287-5","author":"E De Corso","year":"2025","unstructured":"De Corso E, Canonica GW, Heffler E, Springer M, Grzegorzek T, Viana M, et al. Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial. Lancet Respir Med. 2025. https:\/\/doi.org\/10.1016\/s2213-2600(25)00287-5.","journal-title":"Lancet Respir Med"},{"key":"1266_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2021.646956","volume":"15","author":"B Su","year":"2021","unstructured":"Su B, Bleier B, Wei Y, Wu D. Clinical implications of psychophysical olfactory testing: assessment, diagnosis, and treatment outcome. Front Neurosci. 2021;15:1\u201312. https:\/\/doi.org\/10.3389\/fnins.2021.646956.","journal-title":"Front Neurosci"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01266-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-026-01266-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01266-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:43:38Z","timestamp":1774698218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-026-01266-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1266"],"URL":"https:\/\/doi.org\/10.1007\/s11882-026-01266-5","relation":{},"ISSN":["1534-6315"],"issn-type":[{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies\/experiments involving human or animal subjects performed by the authors were in accordance with the ethical standards of institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is a revised version of a previously retracted publication. The original article was retracted due to errors in the statistical analyses that affected parts of the reported results and conclusions. The manuscript has been reanalysed and revised accordingly, with corrected statistical methods, updated results, and amended conclusions where appropriate. The revised article has undergone independent peer review.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Associated Content"}},{"value":"The figures and tables are original. No permissions are needed to reproduce.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permissions"}}],"article-number":"26"}}